hotspot -WSS

hotspot

author：entertainment 2025-08-30 11:02:14 - browse：724

Cambridge: AbbVie — Ruby Wallau for STAT

AbbVie will pay $10 billion for the biotech firm Immunogen, the company said Thursday, acquiring an approved treatment for ovarian cancer and buying into a burgeoning area of oncology.

Under the agreement, AbbVie will pay $31.26 per share in cash for Immunogen, a nearly 100% premium to the company’s recent trading price. Central to the deal, expected to close in the middle of next year, is Elahere, an Immunogen product that won Food and Drug Administration approval for advanced ovarian cancer in 2022.

Elahere is among a surging class of cancer medicines called antibody-drug conjugates, or ADCs, which are designed to deliver a targeted dose of chemotherapy directly to tumor cells while sparing healthy tissues. AbbVie’s acquisition is the latest multibillion-dollar deal in the space, following Merck’s $22 billion agreement with ADC specialist Daiichi Sankyo and Pfizer’s $43 billion buyout of Seagen earlier this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： 30 years of 'Listening to Prozac'

leisure time

explore

WSS

ReNAgade cuts staff seven months after raising $300 million

The EPA's new lead rule: How one expert crunched the numbers

As biotech industry slumps, bioscience job market is upside down

What don’t we know about an Alzheimer’s drug side effect?

What don’t we know about an Alzheimer’s drug side effect?

CDC director unscathed in first congressional testimony

entertainment

hotspot

entertainment

Heart attack and stroke risk calculators need revising

J&J to emphasize cancer drugs, stop much of its vaccine research

At least 13 dead in Texas as scorching temps continue

Will the market for weight loss drugs really reach $100 billion?

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

J&J to emphasize cancer drugs, stop much of its vaccine research

Sports medicine is finally prioritizing gender equality

Brazil's Jair Bolsonaro is barred from running for office until 2030

Alkermes shareholders re

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

explore

CDC director unscathed in first congressional testimony

The strange history of BMI, the body mass index

Despite FDA concern, risk that CAR

GOP inquiry over gain

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Flagship Pioneering launches a new biotech in two countries

knowledge

leisure time

explore

hotspot